Extracellular matrix and the brain: Components and function

Journal of Clinical Neuroscience

Volumn 7, Issue 4, 2000, Pages 280-290

  Novak, Ulrike ^a   Kaye, Andrew H ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Brain; Extracellular matrix; Hyaluronan; Proteoglycan; Receptor

Indexed keywords

AGGRECAN; AGRIN; BREVICAN; CHONDROITIN SULFATE; COLLAGEN; FIBRONECTIN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTEGRIN; LAMININ; LINK PROTEIN; NERVE CELL ADHESION MOLECULE; RECEPTOR PROTEIN; REELIN; TENASCIN; VERSICAN;

CARCINOGENESIS; CELL INTERACTION; CHEMICAL STRUCTURE; DEVELOPMENTAL DISORDER; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE DISTRIBUTION;

EID: 0033852395     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0212     Document Type: Review

References (161)

1. Spicer A. P., Nguyen T. K. Mammalian hyaluronan synthases: investigation of functional relationships in vivo. Biochem Soc Trans. 27:1999;109-115.
2. Weigel P. H., Hascall V. C., Tammi M. Hyaluronan synthases. J Biol Chem. 272:1997;13997-14000.
3. Delpech B., Maingonnat C., Girard N. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer. 29A:1993;1012-1017.
4. Spicer A. P., McDonald J. A. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem. 273:1998;1923-1932.
5. Csoka T. B., Frost G. I., Heng H. H., Scherer S. W., Mohapatra G., Stern R. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics. 48:1998;63-70.
6. Lepperdinger G., Strobl B., Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem. 273:1998;22466-22470.
7. Heckel D., Comtesse N., Brass N., Blin N., Zang K. D., Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet. 7:1998;1859-1872.
8. Gmachl M., Sagan S., Ketter S., Kreil G. The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett. 336:1993;545-548.
9. Liu D., Pearlman E., Diaconu E. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA. 93:1996;7832-7837.
10. Laurent T. C., Laurent U. B., Fraser J. R. The structure and function of hyaluronan: an overview. Immunol Cell Biol. 74:1996;A1-A7.
11. Lees V. C., Fan T. P., West D. C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest. 73:1995;259-266.
12. Fraser J. R., Laurent T. C. Turnover and metabolism of hyaluronan. Ciba Found Symp. 143:1989;41-53.
13. Bouterfa H., Janka M., Meese E., Kerkau S., Roosen K., Tonn J. C. Effect of changes in the CD44 gene on tumour cell invasion in gliomas. Neuropathol Appl Neurobiol. 23:1997;373-379.
14. Rooney P., Wang M., Kumar P., Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci. 105 (Pt 1):1993;213-218.
15. West D. C., Kumar S. Tumour-associated hyaluronan: a potential regulator of tumour angiogenesis. Int J Radiat Biol. 60:1991;55-60.
16. West D. C., Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 183:1989;179-196.
17. Cheung W. F., Cruz T. F., Turley E. A. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem Soc Trans. 27:1999;135-142.
18. Watanabe H., Cheung S. C., Itano N., Kimata K., Yamada Y. Identification of hyaluronan-binding domains of aggrecan. J Biol Chem. 272:1997;28057-28065.
19. Margolis R. U., Margolis R. K. Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol. 245:1994;105-126.
20. Yamada H., Watanabe K., Shimonaka M., Yamasaki M., Yamaguchi Y. cDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican. Biochem Biophys Res Commun. 216:1995;957-963.
21. Schwartz N. B., Domowicz M., Krueger R. C. Jr, Li H., Mangoura D. Brain aggrecan. Perspect Dev Neurobiol. 3:1996;291-306.
22. Milev P., Maurel P., Chiba A. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan versican, neurocan, and brevican. Biochem Biophys Res Commun. 247:1998;207-212.
23. Schmalfeldt M., Dours-Zimmermann M. T., Winterhalter K. H., Zimmermann D. R. Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem. 273:1998;15758-15764.
24. Stigson M., Lofberg J., Kjellen L. Reduced epidermal expression of a PG-M/versican-like proteoglycan in embryos of the white mutant axolotl. Exp Cell Res. 236:1997;57-65.
25. Henderson D. J., Ybot-Gonzalez P., Copp A. J. Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch). Mech Dev. 69:1997;39-51.
26. Rauch U., Karthikeyan L., Maurel P., Margolis R. U., Margolis R. K. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem. 267:1992;19536-19547.
27. Rauch U., Karthikeyan L., Maurel P., Margolis R. U., Margolis R. K. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem. 267:1992;19536-19547.
28. Margolis R. K., Rauch U., Maurel P., Margolis R. U. Neurocan and phosphacan: two major nervous tissue-specific chondroitin sulfate proteoglycans. Perspect Dev Neurobiol. 3:1996;273-290.
29. Engel M., Maurel P., Margolis R. U., Margolis R. K. Chondroitin sulfate proteglycans in the developing central nervous system. I. cellular sites of synthesis of neurocan and phosphacan. J Comp Neurol. 366:1996;34-43.
30. Friedlander D. R., Milev P., Karthikeyan L., Margolis R. K., Margolis R. U., Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol. 125:1994;669-680.
31. Milev P., Maurel P., Haring M., Margolis R. K., Margolis R. U. TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein-tyrosine phosphatase-zeta/beta, and N-CAM. J Biol Chem. 271:1996;15716-15723.
32. Grumet M., Milev P., Sakurai T. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J Biol Chem. 269:1994;12142-12146.
33. Yamada H., Watanabe K., Shimonaka M., Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem. 269:1994;10119-10126.
34. Jaworski D. M., Kelly G. M., Hockfield S. BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain [published erratum appears in J Cell Biol 1997 Apr 21; 137(2): 521]. J Cell Biol. 125:1994;495-509.
35. Seidenbecher C. I., Richter K., Rauch U., Fassler R., Garner C. C., Gundelfinger E. D. Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms. J Biol Chem. 270:1995;27206-27212.
36. Seidenbecher C. I., Gundelfinger E. D., Bockers T. M., Trotter J., Kreutz M. R. Transcripts for secreted and GPI-anchored brevican are differentially distributed in rat brain. Eur J Neurosci. 10:1998;1621-1630.
37. Jaworski D. M., Kelly G. M., Hockfield S. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/Brevican [In Process Citation]. Exp Neurol. 157:1999;327-337.
38. Gary S. C., Kelly G. M., Hockfield S. BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility. Curr Opin Neurobiol. 8:1998;576-581.
39. Watanabe H., Yamada Y. Mice lacking link protein develop dwarfism and craniofacial abnormalities [see comments]. Natl Genet. 21:1999;225-229.
40. Rupp F., Ozcelik T., Linial M., Peterson K., Francke U., Scheller R. Structure and chromosomal localization of the mammalian agrin gene. J Neurosci. 12:1992;3535-3544.
41. Gautam M., Noakes P. G., Moscoso L. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 85:1996;525-535.
42. Cotman S. L., Halfter W., Cole G. J. Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin. Exp Cell Res. 249:1999;54-64.
43. Maurel P., Rauch U., Flad M., Margolis R. K., Margolis R. U. Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc Natl Acad Sci USA. 91:1994;2512-2516.
44. Milev P., Monnerie H., Popp S., Margolis R. K., Margolis R. U. The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J Bio Chem. 273:1998;21439-21442.
45. D'Arcangelo G., Nakajima K., Miyata T., Ogawa M., Mikoshiba K., Curran T. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci. 17:1997;23-31.
46. DeSilva U., D'Arcangelo G., Braden V. V. The human reelin gene: isolation, sequencing, and mapping on chromosome 7 [letter]. Genome Res. 7:1997;157-164.
47. Schiffmann S. N., Bernier B., Goffinet A. M. Reelin mRNA expression during mouse brain development. Eur J Neurosci. 9:1997;1055-1071.
48. Curran T., D'Arcangelo G. Role of reelin in the control of brain development. Brain Res Brain Res Rev. 26:1998;285-294.
49. Chiquet-Ehrismann R., Hagios C., Matsumoto K. The tenascin gene family. Perspect Dev Neurobiol. 2:1994;3-7.
50. Theodosis D. T., Pierre K., Cadoret M. A., Allard M., Faissner A., Poulain D. A. Expression of high levels of the extracellular matrix glycoprotein, tenascin-C, in the normal adult hypothalamoneurohypophysial system. J Comp Neurol. 379:1997;386-398.
51. Tucker R. P., Hammarback J. A., Jenrath D. A., Mackie E. J., Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci. 104 (Pt 1):1993;69-76.
52. Bartsch S., Bartsch U., Dorries U. Expression of tenascin in the developing and adult cerebeller cortex. J Neurosci. 12:1992;736-749.
53. Mitrovic N., Dorries U., Schachner M. Expression of the extracellular matrix glycoprotein tenascin in the somatosensory cortex of the mouse during postnatal development: an immunocytochemical and in situ hybridization analysis. J Neurocytol. 23:1994;364-378.
54. Enam S. A., Rosenblum M. L., Edvardsen K. Role of extracellular matrix in tumor invasion: migration of glioma cells along fibronectin-positive mesenchymal cell processes. Neurosurgery. 42:1998;599-607.
55. Higuchi M., Ohnishi T., Arita N., Hiraga S., Hayakawa T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol (Berl). 85:1993;481-487.
56. Jallo G. I., Friedlander D. R., Kelly P. J., Wisoff J. H., Grumet M., Zagzag D. Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis. Neurosurgery. 41:1997;1052-1059.
57. Zagzag D., Friedlander D. R., Miller D. C. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 55:1995;907-914.
58. Weber P., Bartsch U., Rasband M. N. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci. 19:1999;4245-4262.
59. Brown J. C., Timpl R. The collagen superfamily. Int Arch Allergy Immunol. 107:1995;484-490.
60. Dalgleish R. Collagen gene structure. Biochem Soc Trans. 16:1988;661-663.
61. Prockop D. J., Kivirikko K. I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 64:1995;403-434.
62. Bonadio J., Saunders T. L., Tsai E. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA. 87:1990;7145-7149.
63. Sykes B. Linkage analysis in dominantly inherited osteogenesis imperfecta. Am J Med Genet. 45:1993;212-216.
64. Kornblihtt A. R., Vibe-Pedersen K., Baralle F. E. Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Nat Acad Sci USA. 80:1983;3218-3222.
65. Kornblihtt A. R., Umezawa K., Vibe-Pedersen K., Baralle F. E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 4:1985;1755-1759.
66. Schofield K. P., Humphries M. J., de Wynter E., Testa N., Gallagher J. T. The effect of alpha4 beta1-integrin binding sequences of fibronectin on growth of cells from human hematopoietic progenitors. Blood. 91:1998;3230-3238.
67. Hsieh J. C., Wu C., Chung A. E. The binding of fibronectin to entactin is mediated through the 29 kDa amino terminal fragment of fibronectin and the G2 domain of entactin. Biochem Biophys Res Commun. 199:1994;1509-1517.
68. Vogel T., Werber M. M., Guy R. Studies on fibronectin and its domains. I. Novel recombinant cell- binding domain of fibronetin - a modulator of human platelet functions. Arch Biochem Biophys. 300:1993;501-509.
69. Mould A. P., Burrows L., Humphries M. J. Identification of amino acid residues that form part of the ligand- binding pocket of integrin alpha5 beta1. J Biol Chem. 273:1998;25664-25672.
70. Tashiro K., Sephel G. C., Greatorex D. The RGD containing site of the mouse laminin A chain is active for cell attachment, spreading, migration and neurite outgrowth. J Cell Physiol. 146:1991;451-459.
71. George E. L., Georges-Labouesse E. N., Patel-King R. S., Rayburn H., Hynes R. O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1993;1079-1091.
72. Timpl R., Brown J. C. The laminins. Matrix Biol. 14:1994;275-281.
73. Ryan M. C., Christiano A. M., Engvall E. The functions of laminins: lessons from in vivo studies. Matrix Biol. 15:1996;369-381.
74. Pinkstaff J. K., Detterich J., Lynch G., Gall C. Integrin subunit gene expression is regionally differentiated in adult brain. J Neurosci. 19:1999;1541-1556.
75. Aruffo A., Stamenkovic I., Melnick M., Underhill C. B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
76. Naor D., Sionov R. V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 71:1997;241-319.
77. Takahashi K., Stamenkovic I., Cutler M., Dasgupta A., Tanabe K. K. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem. 271:1996;9490-9496.
78. Culty M., Nguyen H. A., Underhill C. B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 116:1992;1055-1062.
79. Culty M., Shizari M., Thompson E. W., Underhill C. B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol. 160:1994;275-286.
80. Bourguignon L. Y., Gunja-Smith Z. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 176:1998;206-215.
81. Yu Q., Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13:1999;35-48.
82. Zhu D., Bourguignon L. Overexpression of CD44 in p185(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene. 12:1996;2309-2314.
83. Bourguignon L. Y., Zhu H., Chu A., Iida N., Zhang L., Hung M. C. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem. 272:1997;27913-27918.
84. Fieber C., Plug R., Sleeman J., Dall P., Ponta H., Hofmann M. Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM). Gene. 226:1999;41-50.
85. Mohapatra S., Yang X., Wright J. A., Turley E. A., Greenberg A. H. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med. 183:1996;1663-1668.
86. Hall C. L., Turley E. A. Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol. 26:1995;221-229.
87. Paoloni-Giacobino A., Chen H., Antonarakis S. E. Cloning of a novel human neural cell adhesion molecule gene (NCAM2) that maps to chromosome region 21q21 and is potentially involved in Down syndrome. Genomics. 43:1997;43-51.
88. Thompson J., Dickson G., Moore S. E. Alternative splicing of the neural cell adhesion molecule gene generates variant extracellular domain structure in skeletal muscle and brain. Genes Dev. 3:1989;348-357.
89. Gower H. J., Barton C. H., Elsom V. L. Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell. 55:1988;955-964.
90. Tsuru A., Mizuguchi M., Uyemura K., Takashima S. Abnormal expression of cell adhesion molecule L1 in migration disorders: a developmental immunohistochemical study. Clin Neuropathol. 16:1997;122-126.
91. Izumoto S., Ohnishi T., Arita N., Hiraga S., Taki T., Hayakawa T. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res. 56:1996;1440-1444.
92. Tsuzuki T., Izumoto S., Ohnishi T., Hiraga S., Arita N., Hayakawa T. Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53. J Clin Pathol. 51:1998;13-17.
93. Sasaki H., Yoshida K., Ikeda E. Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy. Cancer. 82:1998;1921-1931.
94. Andersson A. M., Moran N., Gaardsvoll H. Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells. Int J Cancer. 47:1991;124-129.
95. Nakajima K., Mikoshiba K., Miyata T., Kudo C., Ogawa M. Disruption of hippocampal development in vivo by CR-50 mAb against reelin. Proc Natl Acad Sci USA. 94:1997;8196-8201.
96. D'Arcangelo G., Miao G. G., Chen S. C., Soares H. D., Morgan J. I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 374:1995;719-723.
97. Wood G. K., Tomasiewicz H., Rutishauser U. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle. Neuroreport. 9:1998;461-466.
98. Fransen E., Lemmon V., van Camp G., Vits L., Coucke P., Willems P. J. CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1 [published erratum appears in Eur J Hum Genet 1996; 4(2): 126]. Eur J Hum.Genet. 3:1995;273-284.
99. Fransen E., D'Hooge R., van Camp G. L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet. 7:1998;999-1009.
100. Turley E. A., Hossain M. Z., Sorokan T., Jordan L. M., Nagy J. I. Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia. 12:1994;68-80.
101. Bertrand P., Girard N., Duval C. Increased hyaluronidase levels in breast tumor metastases. Int J Cancer. 73:1997;327-331.
102. Pham H. T., Block N. L., Lokeshwar V. B. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 57:1997;778-783.
103. Lokeshwar V. B., Soloway M. S., Block N. L. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. Cancer Lett. 131:1998;21-27.
104. Nakano A., Tani E., Miyazaki K., Yamamoto Y., Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg. 83:1995;298-307.
105. Nakagawa T., Kubota T., Kabuto M. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg. 81:1994;69-77.
106. Rooprai H. K., McCormick D. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res. 17:1997;4151-4162.
107. Watanabe K., Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem. 271:1996;22945-22948.
108. Itano N., Sawai T., Yoshida M. Three isoforms of mammalian hyaluronan synthases have dinstinct enzymatic properties. J Biol Chem. 274:1999;25085-25092.
109. Spicer A. P., Olson J. S., McDonald J. A. Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem. 272:1997;8957-8961.
110. Frost G. I., Csoka T. B., Wong T., Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun. 236:1997;10-15.
111. Strobl B., Wechselberger C., Beier D. R., Lepperdinger G. Structural organization and chromosomal localization of Hyal2, a gene encoding a lysosomal hyaluronidase. Genomics. 53:1998;214-219.
112. Csoka A. B., Scherer S. W., Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31 [In Process Citation]. Genomics. 60:1999;356-361.
113. Gmachl M., Kreil G. Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm. Proc Natl Acad Sci USA. 90:1993;3569-3573.
114. Just W., Klett C., Vetter U., Vogel W. Assignment of the human aggrecan gene AGC1 to 15q25->q26.2 by in situ hybridization. Hum Genet. 92:1993;516-518.
115. Heiss N. S., Rogner U. C., Kioschis P., Korn B., Poustka A. Transcription mapping in a 700-kb region around the DXS52 locus in Xq28: isolation of six novel transcripts and a novel ATPase isoform (hPMCA5). Genome Res. 6:1996;478-491.
116. Pulkkinen L., Alitalo T., Krusius T., Peltonen L. Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet Cell Genet. 60:1992;107-111.
117. Cohen I. R., Grassel S., Murdoch A. D., Iozzo R. V. Structural characterization of the complete human perlecan gene and its promoter. Proc Natl Acad Sci USA. 90:1993;10404-10408.
118. Noonan D. M., Hassell J. R. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 43:1993;53-60.
119. Iozzo R. V., Naso M. F., Cannizzaro L. A., Wasmuth J. J., McPherson J. D. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics. 14:1992;845-851.
120. Neame P. J., Barry F. P. The link proteins. Experientia. 49:1993;393-402.
121. Carnemolla B., Leprini A., Borsi L., Querze G., Urbini S., Zardi L. Human tenascin-R. Complete primary structure, pre-mRNA alternative splicing and gene localization on chromosome 1q23-q24. J Biol Chem. 271:1996;8157-8160.
122. Speek M., Barry F., Miller W. L. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5′ and 3′ ends buried in other genes. Hum Mol Genet. 5:1996;1749-1758.
123. Jhanwar S. C., Jensen J. T., Kaelbling M., Chaganti R. S., Klinger H. P. In situ localization of human fibronectin (FN) genes to chromosome regions 2p14-p16, 2q34-q36, and 11q12.1-q13.5 in germ line cells, but to chromosome 2 sites only in somatic cells. Cytogenet Cell Genet. 41:1986;47-53.
124. Carey D. J. Syndecans: multifunctional cell-surface co-receptors. Biochem J. 327 (Pt 1):1997;1-16.
125. Salmivirta M., Jalkanen M. Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules. Experientia. 51:1995;863-872.
126. Cole G. J., Loewy A., Glaser L. Neuronal cell-cell adhesion depends on interactions of N-CAM with heparin-like molecules. Nature. 320:1986;445-447.
127. Storms S. D., Kim A. C., Tran B. H., Cole G. J., Murray B. A. NCAM-mediated adhesion of transfected cells to agrin. Cell Adhes Commun. 3:1996;497-509.
128. Demyanenko G. P., Tsai A. Y., Maness P. F. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. J Neurosci. 19:1999;4907-4920.
129. Hortsch M. The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron. 17:1996;587-593.
130. Watanabe H., Nakata K., Kimata K., Nakanishi I., Yamada Y. Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan. Proc Natl Acad Sci USA. 94:1997;6943-6947.
131. Lamande S. R., Dahl H. H., Cole W. G., Bateman J. F. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. J Biol Chem. 264:1989;15809-15812.
132. Pihlajaniemi T., Dickson L. A., Pope F. M. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem. 259:1984;12941-12944.
133. Li S. W., Prockop D. J., Helminen H. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev. 9:1995;2821-2830.
134. Johnson P. H., Richards A. J., Pope F. M., Hopkinson D. A. A COL3A1 glycine 1006 to glutamic acid substitution in a patient with Ehlers-Danlos syndrome type IV detected by denaturing gradient gel electrophoresis. J Inherit Metab Dis. 15:1992;426-430.
135. Liu X., Wu H., Byrne M., Krane S., Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA. 94:1997;1852-1856.
136. Uitto J., Chung-Honet L. C., Christiano A. M. Molecular biology and pathology of type VII collagen. Exp Dermatol. 1:1992;2-11.
137. Bruckner-Tuderman L. Collagen VII and bullous disorders of the skin. Dermatology. 189 Suppl 2:1994;16-20.
138. Zhang X., Vuolteenaho R., Tryggvason K. Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem. 271:1996;27664-27669.
139. Helbling-Leclerc A., Zhang X., Topaloglu H. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin- deficient congenital muscular dystrophy. Nat Genet. 11:1995;216-218.
140. Vidal F., Baudoin C., Miquel C. Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics. 30:1995;273-280.
141. Pulkkinen L., Gerecke D. R., Christiano A. M., Wagman D. W., Burgeson R. E., Uitto J. Cloning of the beta 3 chain gene (LAMB3) of human laminin 5, a candidate gene in junctional epidermolysis bullosa. Genomics. 25:1995;192-198.
142. Pulkkinen L., McGrath J., Airenne T. Detection of novel LAMC2 mutations in Herlitz junctional epidermolysis bullosa. Mol Med. 3:1997;124-135.
143. de Bergeyck V., Nakajima K., Lambert dR., Naerhuyzen B., Goffinet A. M., Miyata T. A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res Mol Brain Res. 50:1997;85-90.
144. Saga Y., Yagi T., Ikawa Y., Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev. 6:1992;1821-1831.
145. Milev P., Fischer D., Haring M. The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta. J Biol Chem. 272:1997;15501-15509.
146. Cremer H., Chazal G., Carleton A., Goridis C., Vincent J. D., Lledo P. M. Long-term but not short-term plasticity at mossy fiber synapses is impaired in neural cell adhesion molecule-deficient mice. Proc Natl Acad Sci USA. 95:1998;13242-13247.
147. Scotland P., Zhou D., Benveniste H., Bennett V. Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol. 143:1998;1305-1315.
148. Gardner H., Kreidberg J., Koteliansky V., Jaenisch R. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol. 175:1996;301-313.
149. Pozzi A., Wary K. K., Giancotti F. G., Gardner H. A. Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol. 142:1998;587-594.
150. Tadokoro S., Tomiyama Y., Honda S. A Gln747->Pro substitution in the Ilb subunit is responsible for a moderate IIbbeta3 deficiency in Glanzmann thrombasthenia. Blood. 92:1998;2750-2758.
151. Honda S., Tomiyama Y., Shiraga M. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding. J Clin Invest. 102:1998;1183-1192.
152. Kreidberg J. A., Donovan M. J., Goldstein S. L. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development. 122:1996;3537-3547.
153. Pulkkinen L., Kimonis V. E., Xu Y., Spanou E. N., McLean W. H., Uitto J. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet. 6:1997;669-674.
154. Gache Y., Romero-Graillet C., Spadafora A. A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination [letter]. J Invest Dermatol. 111:1998;914-916.
155. Hayashi Y. K., Chou F. L., Engvall E. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet. 19:1998;94-97.
156. Stephens L. E., Sutherland A. E., Klimanskaya I. V. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 9:1995;1883-1895.
157. Bajt M. L., Ginsberg M. H., Frelinger A. L. I. I. I., Berndt M. C., Loftus J. C. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem. 267:1992;3789-3794.
158. Chen Y. P., Djaffar I., Pidard D. Ser-752->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA. 89:1992;10169-10173.
159. Hodivala-Dilke K. M., McHugh K. P., Tsakiris D. A. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 103:1999;229-238.
160. Mellerio J. E., Pulkkinen L., McMillan J. R. Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease. Br J Dermatol. 139:1998;862-871.
161. Dowling J., Yu Q. C., Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 134:1996;559-572.